Literature DB >> 15516385

Trends in congenital malformations, 1974-1999: effect of prenatal diagnosis and elective termination.

Allyson J Peller1, Marie-Noel Westgate, Lewis B Holmes.   

Abstract

OBJECTIVE: To examine trends in congenital malformations, elective terminations for malformations and correlates for the decision to terminate a pregnancy with a malformation.
METHODS: All malformed liveborn and stillborn infants and elective terminations for malformations were identified in a large urban tertiary center and general hospital for the years 1974, 1979, 1984, 1989, 1994, and 1999. Nine hundred and fifty-four women with malformed infants, who had always planned to deliver at the hospital, were identified. Prenatal screening by ultrasonography or amniocentesis before 24 weeks of gestation, severity rating of the malformation, parity, marital status, race, level of education, insurance status, and pregnancy history were determined
RESULTS: In each of these 6 years, about 2% of newborn infants had a major malformation. The rate of prenatal screening by ultrasonography and amniocentesis before 24 weeks increased from 7% in the years 1974 and 1979 to 61% in the years 1984 and 1989 to 89% in the years 1994 and 1999. Elective termination increased from less than 1% in the years 1974 and 1979 to 18% to 20% in the years 1984, 1989, 1994, and 1999. Pregnancies with fatal and severe conditions were much more likely to be terminated electively than pregnancies with moderate or mild conditions (odds ratio 53.3; 95% confidence interval 22.7-124.7)
CONCLUSION: The introduction of routine prenatal screening and the subsequent increase in elective termination for malformed fetuses means that the inclusion of terminated pregnancies in malformation surveillance programs is necessary to study prevalence and risk factors in the epidemiology of malformations.

Entities:  

Mesh:

Year:  2004        PMID: 15516385     DOI: 10.1097/01.AOG.0000142718.53380.8f

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  18 in total

1.  Awareness and attitudes regarding prenatal testing among Texas women of childbearing age.

Authors:  Amy P Case; Tunu A Ramadhani; Mark A Canfield; Catherine A Wicklund
Journal:  J Genet Couns       Date:  2007-08-03       Impact factor: 2.537

2.  Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: Featuring critical congenital heart defects targeted for pulse oximetry screening.

Authors:  Cara T Mai; Tiffany Riehle-Colarusso; Alissa O'Halloran; Janet D Cragan; Richard S Olney; Angela Lin; Marcia Feldkamp; Lorenzo D Botto; Russel Rickard; Marlene Anderka; Mary Ethen; Carol Stanton; Joan Ehrhardt; Mark Canfield
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-12

3.  Invasive prenatal genetic testing: A Catholic healthcare provider's perspective.

Authors:  Jay J Bringman
Journal:  Linacre Q       Date:  2014-11

Review 4.  Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature.

Authors:  Candice Y Johnson; Margaret A Honein; W Dana Flanders; Penelope P Howards; Godfrey P Oakley; Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-10-25

5.  Case-control studies for identifying novel teratogens.

Authors:  Martha M Werler; Carol Louik; Allen A Mitchell
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-07-15       Impact factor: 3.908

6.  Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials.

Authors:  Sonja A Rasmussen; Sonia Hernandez-Diaz; Omar A Abdul-Rahman; Leyla Sahin; Carey R Petrie; Kim M Keppler-Noreuil; Sharon E Frey; Robin M Mason; Mirjana Nesin; John C Carey
Journal:  Clin Infect Dis       Date:  2014-12-15       Impact factor: 9.079

7.  Alteration of bioelectrically-controlled processes in the embryo: a teratogenic mechanism for anticonvulsants.

Authors:  Sonia Hernández-Díaz; Michael Levin
Journal:  Reprod Toxicol       Date:  2014-05-06       Impact factor: 3.143

8.  Taking ACE inhibitors during early pregnancy: is it safe?

Authors:  Joel G Ray; Marian J Vermeulen; Gideon Koren
Journal:  Can Fam Physician       Date:  2007-09       Impact factor: 3.275

9.  Medical databases in studies of drug teratogenicity: methodological issues.

Authors:  Vera Ehrenstein; Henrik T Sørensen; Leiv S Bakketeig; Lars Pedersen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

10.  Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada.

Authors:  Raluca Ionescu-Ittu; Ariane J Marelli; Andrew S Mackie; Louise Pilote
Journal:  BMJ       Date:  2009-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.